Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/30287
Title: Association of Dual Decline in Cognition and Gait Speed With Risk of Dementia in Older Adults.
Austin Authors: Collyer, Taya A;Murray, Anne M;Woods, Robyn L;Storey, Elsdon;Chong, Trevor T-J;Ryan, Joanne;Orchard, Suzanne G;Brodtmann, Amy ;Srikanth, Velandai K;Shah, Raj C;Callisaya, Michele L
Affiliation: University of Melbourne, Melbourne, Victoria, Australia..
Turner Institute for Brain and Mental Health, Monash University, Victoria, Australia..
Department of Neurology, Alfred Health, Melbourne, Victoria, Australia..
Department of Clinical Neurosciences, St Vincent's Hospital, Melbourne, Victoria, Australia..
The Florey Institute of Neuroscience and Mental Health
School of Public Health and Preventative Medicine, Monash University, Melbourne, Victoria, Australia..
Peninsula Clinical School, Central Clinical School, Monash University, Frankston, Victoria, Australia..
Berman Center for Outcomes and Clinical Research, Hennepin Health Research Institute, Hennepin Healthcare and University of Minnesota, Minneapolis..
Department of Family Medicine and Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, Illinois..
Issue Date: 2-May-2022
Date: 2022
Publication information: JAMA network open 2022; 5(5): e2214647
Abstract: Dual decline in gait speed and cognition has been found to be associated with increased dementia risk in previous studies. However, it is unclear if risks are conferred by a decline in domain-specific cognition and gait. To examine associations between dual decline in gait speed and cognition (ie, global, memory, processing speed, and verbal fluency) with risk of dementia. This cohort study used data from older adults in Australia and the US who participated in a randomized clinical trial testing low-dose aspirin between 2010 and 2017. Eligible participants in the original trial were aged 70 years or older, or 65 years or older for US participants identifying as African American or Hispanic. Data analysis was performed between October 2020 and November 2021. Gait speed, measured at 0, 2, 4, and 6 years and trial close-out in 2017. Cognitive measures included Modified Mini-Mental State examination (3MS) for global cognition, Hopkins Verbal Learning Test-Revised (HVLT-R) for memory, Symbol Digit Modalities (SDMT) for processing speed, and Controlled Oral Word Association Test (COWAT-F) for verbal fluency, assessed at years 0, 1, 3, 5, and close-out. Participants were classified into 4 groups: dual decline in gait and cognition, gait decline only, cognitive decline only, and nondecliners. Cognitive decline was defined as membership of the lowest tertile of annual change. Gait decline was defined as a decline in gait speed of 0.05 m/s or greater per year across the study. Dementia (using Diagnostic and Statistical Manual of Mental Disorders [Fourth Edition] criteria) was adjudicated by an expert panel using cognitive tests, functional status, and clinical records. Cox proportional hazard models were used to estimate risk of dementia adjusting for covariates, with death as competing risk. Of 19 114 randomized participants, 16 855 (88.2%) had longitudinal gait and cognitive data for inclusion in this study (mean [SD] age, 75.0 [4.4] years; 9435 women [56.0%], 7558 participants [44.8%] with 12 or more years of education). Compared with nondecliners, risk of dementia was highest in the gait plus HVLT-R decliners (hazard ratio [HR], 24.7; 95% CI, 16.3-37.3), followed by the gait plus 3MS (HR, 22.2; 95% CI, 15.0-32.9), gait plus COWAT-F (HR, 4.7; 95% CI, 3.5-6.3), and gait plus SDMT (HR, 4.3; 95% CI, 3.2-5.8) groups. Dual decliners had a higher risk of dementia than those with either gait or cognitive decline alone for 3MS and HVLT-R. Of domains examined, the combination of decline in gait speed with memory had the strongest association with dementia risk. These findings support the inclusion of gait speed in dementia risk screening assessments.
URI: https://ahro.austin.org.au/austinjspui/handle/1/30287
DOI: 10.1001/jamanetworkopen.2022.14647
ORCID: 0000-0001-9466-2862
Journal: JAMA network open
PubMed URL: 35639376
PubMed URL: https://pubmed.ncbi.nlm.nih.gov/35639376/
Type: Journal Article
Appears in Collections:Journal articles

Show full item record

Page view(s)

26
checked on Nov 21, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.